Building on a decade of success, IV is pleased to announce that Global Good projects have transitioned to the Bill & Melinda Gates Foundation and Gates Ventures.Read More
Filter By Category
Global Good is helping families prepare meals with cleaner, more efficient cooking by embedding technology into Jet Flame Cookstove.Read More
Global Good recently donated three INCUDIGIT-SV 30 biological culture incubators to the Governor’s office of Lagos State.Read More
Global Good recently conducted a World Cancer Day 2019 webinar called Artificial Intelligence for Identifying Cervical Precancer, which explores how a new Automated Visual Evaluation (AVE) technique will potentially increase access to quality cervical cancer screening worldwide.Read More
Intellectual Ventures and Toler Law Group Collaborate to Give High-Growth Private Software Technology Companies Valuable Access to Patent Portfolio
New patent licensing program allows select software and application technology services companies greater access to IV’s vast patent portfolio.Read More
Mangata Networks Selected by 5G Open Innovation Lab to Help Drive Early Adoption and Innovation of 5G Technology
Mangata Networks to Provide Affordable High Capacity 5G Over Satellite Global SolutionsRead More
IP industry veteran to lead commercialization strategy and execution, business development.Read More
The new patent licensing program will allow select companies in the IoT space access IV’s unparalleled patent portfolio.Read More
New Prototype Screened Doors and Windows for Excluding Mosquitoes from Houses: A Pilot Study in Rural Gambia.
With partners, Global Good is redesigning the window and door to keep deadly mosquitoes out of African homes.Read More
Automated microscopy for routine malaria diagnosis: a field comparison on Giemsa-stained blood films in Peru.
Autoscope was tested in the Iquitos region of Peru in 2016 at two peripheral health facilities, with routine microscopy and PCR as reference standards. The main outcome measures include sensitivity and specificity of diagnosis of malaria from Giemsa-stained blood films, using PCR as reference.Read More
Polydisperse emulsion digital assay to enhance time to detection and extend dynamic range in bacterial cultures enabled by a statistical framework.
Microbiological culture remains the most sensitive method for detecting viable and infectious bacteria, but these methods often require at least 24 hours to visibly identify bacterial growth.Read More
Here, we review the principles underpinning lateral flow assays and the historical evolution of theory to predict their performance.Read More
The New York Times
The New York Times calls Nathan Myhrvold, IV Founder and CEO, “One of the first people to realize the commercial potential of metamaterials…” Learn more about this exciting, emerging space that IV has been instrumental in for well over a decade.Read More
IV spinout Echodyne recently teamed up with NASA to prove drones can fly autonomously in crowded airspace.Read More
The Wall Street Journal
IV spinout Evolv Technology is combining with a SPAC to go public in a deal that values the crowd-safety firm at about $1.7 billion.Read More